Keyword Analysis & Research: lovenox pregnancy
Keyword Research: People who searched lovenox pregnancy also searched
Search Results related to lovenox pregnancy on Search Engine
-
Use of anticoagulants during pregnancy and postpartum
https://www.uptodate.com/contents/use-of-anticoagulants-during-pregnancy-and-postpartum
WEBDec 21, 2023 · Anticoagulation is sometimes needed during pregnancy and/or the postpartum period in individuals at high risk of deep vein thrombosis, a history of venous thromboembolism, with prosthetic heart valves, atrial fibrillation, left ventricular dysfunction, or a history of fetal loss.
DA: 32 PA: 91 MOZ Rank: 40
-
Anticoagulation During Pregnancy | ASH Clinical News
https://ashpublications.org/ashclinicalnews/news/3532/Anticoagulation-During-Pregnancy
WEBEmerging data have suggested that the standard prophylactic doses for the general population (enoxaparin 40 mg/day or dalteparin 5,000 IU/day) are insufficient for anticoagulation during pregnancy. The jury is out about the optimal dose, though.
DA: 51 PA: 85 MOZ Rank: 96
-
What to Know About Lovenox During Pregnancy - Verywell Family
https://www.verywellfamily.com/what-to-know-about-lovenox-during-pregnancy-5184489
WEBSep 21, 2022 · If you are at high risk for blood clots in pregnancy, or if you are currently experiencing a blood clot during pregnancy, you are probably wondering if Lovenox is a good choice for you. You may be asking if Lovenox is safe for you and your growing baby, and what the side effects might be.
DA: 33 PA: 61 MOZ Rank: 17
-
Venous Thromboembolism During Pregnancy | AAFP
https://www.aafp.org/pubs/afp/issues/2008/0615/p1709.html
WEBJun 15, 2008 · Venous thromboembolism is the leading cause of maternal death in the United States. Pregnancy is a risk factor for deep venous thrombosis, and risk is further increased with a personal or family...
DA: 26 PA: 12 MOZ Rank: 74
-
Safety and Efficacy of Enoxaparin in Pregnancy: A Systematic …
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6979442/
WEBOct 31, 2019 · In terms of safety, enoxaparin use in pregnancy was associated with a significantly lower occurrence of pregnancy loss when compared with control groups and similar rates of bleeding when compared with aspirin; reports of thromboembolic events, thrombocytopenia, and teratogenicity were rare.
DA: 49 PA: 31 MOZ Rank: 9
-
Enoxaparin Use During Pregnancy | Drugs.com
https://www.drugs.com/pregnancy/enoxaparin.html
WEBJul 5, 2023 · Brand names: Clexane, Clexane Forte, Lovenox, Lovenox HP. Medically reviewed by Drugs.com. Last updated on Jul 5, 2023. Pregnancy Warnings. Breastfeeding Warnings. Enoxaparin Pregnancy Warnings. Animal studies have failed to reveal evidence of teratogenicity.
DA: 69 PA: 91 MOZ Rank: 38
-
Thromboembolism in Pregnancy | ACOG
https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2018/07/thromboembolism-in-pregnancy
WEBABSTRACT: Women who are pregnant or in the postpartum period have a fourfold to fivefold increased risk of thromboembolism compared with nonpregnant women 1 2. Approximately 80% of thromboembolic events in pregnancy are venous 3, with a prevalence of 0.5–2.0 per 1,000 pregnant women 4 5 6 7 8 9.
DA: 3 PA: 70 MOZ Rank: 10
-
Venous thromboembolism in pregnancy and postpartum: Treatment
https://www.uptodate.com/contents/venous-thromboembolism-in-pregnancy-and-postpartum-treatment
WEBJun 21, 2023 · Literature review current through: Feb 2024. This topic last updated: Jun 21, 2023. INTRODUCTION. Lower extremity deep vein thrombosis (DVT) and pulmonary embolism (PE) are collectively referred to as venous thromboembolism (VTE). Pregnancy and the postpartum period are well-established risk factors for VTE.
DA: 59 PA: 99 MOZ Rank: 29
-
How I treat venous thromboembolism in pregnancy
https://ashpublications.org/blood/article/136/19/2133/463258/How-I-treat-venous-thromboembolism-in-pregnancy
WEBNov 5, 2020 · Low molecular weight heparin (LMWH) in therapeutic doses is the treatment of choice during pregnancy, and anticoagulation (LMWH or vitamin K antagonists [VKAs]) should be continued until 6 weeks after delivery, with a 3-month minimum total duration. LMWH or VKA use does not preclude breastfeeding.
DA: 53 PA: 3 MOZ Rank: 13
-
Safety and Efficacy of Enoxaparin in Pregnancy: A Systematic
https://pubmed.ncbi.nlm.nih.gov/31673991/
WEBIntroduction: International guidelines support the use of low molecular weight heparins for the treatment of thromboembolism and thromboprophylaxis during pregnancy. However, evidence of the benefit and harm associated with specific low molecular weight heparins such as enoxaparin is dated.
DA: 44 PA: 25 MOZ Rank: 95
